Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ced.14411 http://scihub22266oqcxt.onion/10.1111/ced.14411 32754962!7436874!32754962     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Dermatol 2021 ; 46 (1): 145-146 Nephropedia Template TP {{tp|p=32754962|t=2021. Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic |pdf=|usr=}}{{32754962}} gab.com Text Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic JO: Clin Exp Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=32754962 #FOAvip The UK healthcare system, including skin cancer departments, has been profoundly affected by the COVID-19 pandemic. Despite service capacity and a worldwide increase in incidence, anecdotal reports suggest a decline in skin cancer diagnoses following COVID-19. To determine if there has been a decrease in skin cancer diagnosis in the UK in the COVID-19 era, we analysed data from the Northern Cancer Network from 23 March 2020 to 23 June 2020 and compared it with the same period in 2019 (pre-COVID). In the COVID period, there was a decrease of 68.61% in skin cancer diagnoses, from 3619 to 1136 (P < 0.01). Surprisingly, skin cancer waiting times were also reduced in the COVID period compared to the pre-COVID period (median of 8 and 12 days, respectively; P < 0.001). Collectively, these data highlight a statistically significant reduction in both skin cancer diagnoses and waiting times during the COVID period. Twit Text FOAVip Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic ????Clin Exp Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=32754962 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32754962 #FOAvip English Wikipedia <ref>{{Cite pmid|32754962}}</ref> Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic #MMPMID32754962 Andrew TW; Alrawi M; Lovat P Clin Exp Dermatol 2021[Jan]; 46 (1): 145-146 PMID32754962show ga The UK healthcare system, including skin cancer departments, has been profoundly affected by the COVID-19 pandemic. Despite service capacity and a worldwide increase in incidence, anecdotal reports suggest a decline in skin cancer diagnoses following COVID-19. To determine if there has been a decrease in skin cancer diagnosis in the UK in the COVID-19 era, we analysed data from the Northern Cancer Network from 23 March 2020 to 23 June 2020 and compared it with the same period in 2019 (pre-COVID). In the COVID period, there was a decrease of 68.61% in skin cancer diagnoses, from 3619 to 1136 (P < 0.01). Surprisingly, skin cancer waiting times were also reduced in the COVID period compared to the pre-COVID period (median of 8 and 12 days, respectively; P < 0.001). Collectively, these data highlight a statistically significant reduction in both skin cancer diagnoses and waiting times during the COVID period. |COVID-19/*epidemiology/virology[MESH] |Clinical Decision-Making[MESH] |Delivery of Health Care/*statistics & numerical data[MESH] |Humans[MESH] |Incidence[MESH] |SARS-CoV-2/*genetics[MESH] |Skin Neoplasms/*diagnosis/epidemiology[MESH] |Telemedicine/instrumentation[MESH]Reduction in skin cancer diagnoses in the UK during the COVID-19 pande(epmc).pdf DeepDyve Pubget Overpricing